伪劣医疗产品: 总干事的报告
| dc.coverage | 日内瓦 | |
| dc.creator | 执行委员会, 148 | |
| dc.date | 2022-07-11T16:38:01Z | |
| dc.date | 2022-07-11T16:38:01Z | |
| dc.date | 2021-12-31 | |
| dc.date.accessioned | 2026-08-03T14:30:13Z | |
| dc.description | 15 页 | |
| dc.format | application/pdf | |
| dc.identifier | EB148/12 | |
| dc.identifier | https://iris.who.int/handle/10665/359573 | |
| dc.identifier.uri | https://repo.dare.co.zw/handle/123456789/267577 | |
| dc.language | 中文 | |
| dc.language | zh | |
| dc.publisher | 世界卫生组织 | |
| dc.subject | Drug Industry | |
| dc.subject | Pharmaceutical Preparations | |
| dc.subject | Counterfeit Drugs | |
| dc.subject | Drug Contamination | |
| dc.subject | Fraud | |
| dc.subject | International Cooperation | |
| dc.subject | Quality Control | |
| dc.title | 伪劣医疗产品: 总干事的报告 | |
| dc.type | Governing Bodies documents |